To ascertain the effects of blocking the IFN-γ pathway in the cancer cells, activation of the downstream signaling molecule STAT1 was monitored by measuring phosphorylated STAT1 (p-STAT1) related to total STAT1 (t-STAT1) (Fig. 5c). The gene discussed is IFNG; the disease is cancer.